Natixis Has $2.46 Million Stock Position in H. B. Fuller Company $FUL

Natixis boosted its holdings in shares of H. B. Fuller Company (NYSE:FUL) by 358.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,932 shares of the specialty chemicals company’s stock after purchasing an additional 32,000 shares during the period. Natixis owned about 0.08% of H. B. Fuller worth $2,462,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Parallel Advisors LLC raised its holdings in shares of H. B. Fuller by 141.6% during the 2nd quarter. Parallel Advisors LLC now owns 534 shares of the specialty chemicals company’s stock worth $32,000 after buying an additional 313 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in H. B. Fuller by 129.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock valued at $73,000 after buying an additional 688 shares in the last quarter. Strs Ohio bought a new position in H. B. Fuller in the first quarter valued at about $101,000. Signaturefd LLC raised its stake in H. B. Fuller by 20.5% during the second quarter. Signaturefd LLC now owns 1,743 shares of the specialty chemicals company’s stock worth $105,000 after acquiring an additional 297 shares in the last quarter. Finally, Huntington National Bank raised its stake in H. B. Fuller by 23.9% during the second quarter. Huntington National Bank now owns 2,236 shares of the specialty chemicals company’s stock worth $134,000 after acquiring an additional 432 shares in the last quarter. Institutional investors and hedge funds own 95.93% of the company’s stock.

H. B. Fuller Stock Up 3.5%

NYSE:FUL opened at $59.54 on Thursday. H. B. Fuller Company has a one year low of $47.56 and a one year high of $76.10. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.93 and a quick ratio of 1.18. The company has a market cap of $3.22 billion, a PE ratio of 32.19, a P/E/G ratio of 0.93 and a beta of 1.09. The firm’s 50 day simple moving average is $58.29 and its 200 day simple moving average is $58.77.

H. B. Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 earnings per share (EPS) for the quarter. The firm had revenue of $725.90 million during the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. On average, research analysts anticipate that H. B. Fuller Company will post 4.07 earnings per share for the current year.

H. B. Fuller Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, October 30th. Investors of record on Thursday, October 16th were given a dividend of $0.235 per share. This represents a $0.94 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend was Thursday, October 16th. H. B. Fuller’s dividend payout ratio (DPR) is currently 50.81%.

Insider Activity

In other H. B. Fuller news, CFO John J. Corkrean sold 14,222 shares of the company’s stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $60.31, for a total value of $857,728.82. Following the sale, the chief financial officer owned 54,646 shares in the company, valued at approximately $3,295,700.26. The trade was a 20.65% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Nathan D. Weaver sold 7,075 shares of the firm’s stock in a transaction dated Thursday, November 13th. The stock was sold at an average price of $58.38, for a total value of $413,038.50. Following the transaction, the vice president owned 9,441 shares of the company’s stock, valued at $551,165.58. This trade represents a 42.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.99% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

FUL has been the topic of a number of research analyst reports. Wall Street Zen downgraded shares of H. B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. UBS Group began coverage on shares of H. B. Fuller in a research note on Friday, November 21st. They issued a “neutral” rating and a $60.00 price objective for the company. Weiss Ratings restated a “hold (c-)” rating on shares of H. B. Fuller in a research report on Monday, December 1st. Seaport Res Ptn raised shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Finally, Citigroup upgraded shares of H. B. Fuller from a “neutral” rating to a “buy” rating and upped their price target for the stock from $62.00 to $70.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $66.20.

H. B. Fuller Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.